Onaiza Cadoret-Manier
Director/Board Member at ARDELYX, INC.
Net worth: 2 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Raju Mohan | M | 67 | 6 years | |
| Justin Renz | M | 52 | 4 years | |
| David Mott | M | 58 | 15 years | |
| Robert Felsch | M | - | 4 years | |
| Elizabeth Grammer | F | 60 | 12 years | |
| Mike Raab Raab | M | 59 | 15 years | |
| William Bertrand | M | 59 | 9 years | |
| Richard Rodgers | M | 57 | 10 years | |
| Caitlin Lowie | F | - | 2 years | |
| Muna Bhanji | F | 61 | 3 years | |
| Joseph Baroldi | M | 46 | 14 years | |
| William White | M | 51 | 3 years | |
| Laura Williams | M | 61 | 4 years | |
| Robert Bazemore | M | 56 | 8 years | |
| Allene Diaz | F | 59 | 3 years | |
| Allison Hulme | M | 61 | 1 years | |
| Somu Subramaniam | M | 69 | 6 years | |
| Hal Barron | M | 62 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 24 years |
| Jan Lundberg | M | 71 | 6 years | |
| D. Walke | M | 58 | 1 years | |
| Susan Rodriguez | F | 60 | 4 years | |
| Robert Blanks | M | 64 | 11 years | |
| Dawn Henson | F | - | 4 years | |
| Eric P. Bastings | M | - | 2 years | |
| Richard P. Strubel | M | 84 |
The University of Chicago
| 37 years |
| Kyle Jenne | M | 48 | - | |
| Darren Gonzales | M | - | 4 years | |
| Martin Auster | M | 49 | 3 years | |
| Sheila Gujrathi | M | 53 | 3 years | |
| David Rosenbaum | M | 63 | 14 years | |
| Michael Yang | M | 62 | 1 years | |
| John Nuss | M | 65 | 5 years | |
| Charon Spencer | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stanley Crooke | M | 78 | 32 years | |
| Mark E. Kaufmann | M | 56 | 9 years | |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Keith Santorelli | M | - | - | |
| Richard C. Wirthlin | M | - |
The University of Chicago
| 3 years |
| Alex Aravanis | M | 48 |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | 2 years |
| George Golumbeski | M | 67 |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | 1 years |
| Jeffrey W. Jacobs | M | 61 | 13 years | |
| Geoffrey A. Block | M | 58 | 4 years | |
| Mark Phelan | M | 55 |
The University of Chicago
| 3 years |
| Bill Bergman | M | - |
The University of Chicago
| 3 years |
| Alok Gaur | M | - |
The University of Chicago
| 6 years |
| Annalisa Jenkins | M | 58 | 5 years | |
| Jakob Dupont | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Jeremy Feigelson | M | - |
The University of Chicago
| 3 years |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
| Daniel J. Young | M | - |
The University of Chicago
| 4 years |
| Joseph Werne | M | - |
The University of Chicago
| 5 years |
| Carla N. Taylor | F | - |
The University of Chicago
| 6 years |
| Stanley Ryan | M | 62 |
The University of Chicago
| 2 years |
| William Sandborn | M | 61 | 1 years | |
| Ryan Watts | M | 48 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Asha Das | M | 59 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Aaron Royston | M | 40 | 2 years | |
| Jigar Choksey | M | 38 | 2 years | |
| June Lee | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Catherine Stehman-Breen | M | 61 |
The University of Chicago
| 3 years |
| Roslyn Patterson | F | - | 5 years | |
| William Anderson | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Richard Gaster | M | 40 | 2 years | |
| Mark Nydam | M | - |
The University of Chicago
| 3 years |
| Breaux B. Castleman | M | 83 | 8 years | |
| William C. Stern | M | 60 |
The University of Chicago
| 3 years |
| Arthur Levinson | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 19 years |
| Gordon Ringold | M | 73 | 7 years | |
| Frederick Muto | M | 70 | 21 years | |
| May Kin Ho | M | 71 |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | 2 years |
| David Abramson | M | - |
The University of Chicago
| 2 years |
| Peter N. Reikes | M | 63 | 3 years | |
| Byung-Do Kim | M | 65 |
The University of Chicago
| 4 years |
| John P. Remmert | M | - |
The University of Chicago
| 3 years |
| Liwei Xu | M | - |
The University of Chicago
| 3 years |
| Joshua Chad Leibowitz | M | 53 |
The University of Chicago
| 4 years |
| Catherine Kozik | F | - |
The University of Chicago
| 2 years |
| Tony N. Pritzker | M | 63 |
The University of Chicago
| 2 years |
| Shawn Del Monaghan | M | - |
The University of Chicago
| 2 years |
| Xunming Deng | M | - |
The University of Chicago
| 3 years |
| Henry S. Romaine | M | 60 |
The University of Chicago
| 2 years |
| John Clifton Pickart | M | - |
The University of Chicago
| 2 years |
| Jason B. Selch | M | 62 |
The University of Chicago
| 2 years |
| John Berding | M | 61 |
The University of Chicago
| 2 years |
| Russell D. Burks | M | - |
The University of Chicago
| 2 years |
| Beth G. Etscheid | M | - |
The University of Chicago
| 6 years |
| Pesavento Anthony | M | - |
The University of Chicago
| 2 years |
| Jeffrey Beyer | M | - |
The University of Chicago
| 5 years |
| Nicholas Donald Tannura | M | - |
The University of Chicago
| 2 years |
| Robert Lawrence Arnold | M | 60 |
The University of Chicago
| 2 years |
| Russell M. Wofford | M | - |
The University of Chicago
| 3 years |
| Michel Prince | M | - |
The University of Chicago
| 2 years |
| Ja-Eun Koo | M | 60 |
The University of Chicago
| 2 years |
| Gregory N. Taylor | M | - |
The University of Chicago
| 3 years |
| Michael J. Small | M | - |
The University of Chicago
| 3 years |
| Phillipa White | F | - |
The University of Chicago
| 4 years |
| Jackson Ricardo Gomes | M | 66 |
The University of Chicago
| 2 years |
| Timothy G. Peara | M | 63 |
The University of Chicago
| 2 years |
| Joseph R. Eshoo | M | - |
The University of Chicago
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Onaiza Cadoret-Manier
- Personal Network
